Shandong Lukang Pharmaceutical Co., Ltd. Risk Report
Explore Shandong Lukang Pharmaceutical Co., Ltd. across six non‑financial risk dimensions:ESG, Workforce, News & Media, Cybersecurity, Legal & Regulatory, Operational. Unlock the full report, original sources and timelines, and enable continuous monitoring.
Summary
🏗️ Operational & Business Continuity
Shandong Lukang Pharmaceutical Co., Ltd. does not have any direct recent news about operational disruptions. However, general market activities in the pharmaceutical sector, such as those in which the company participates, indicate continuous evolution and business engagements.
- Orion established a tuberculosis vaccine plant in Jining 🗓 2022-07-13, which reflects ongoing investment in China's healthcare infrastructure.
- Genomictree made significant progress in China's cancer diagnostic market with its EarlyTect-C deal 🗓 2025-06-12.
📜 Innovation & R&D
Innovation is a critical focus for Shandong Lukang Pharmaceutical, with developments in global pharmaceutical and diagnostics markets suggesting a state of active research and development. Such advancements are pivotal in maintaining competitiveness and fostering growth in the pharmaceutical industry.
- Genomictree's diagnostic technology achieved a key milestone 🗓 2025-06-12, underscoring the importance of innovative efforts in medical diagnosis.
Profile
News & Media
Real‑time aggregation of trusted sources tracking company‑related events with sentiment and topic tags for rapid risk triage.
Sign up to unlock Shandong Lukang Pharmaceutical Co., Ltd.’s complete news feed with sentiment and topic tags.
View Full ReportEntity List
Continuous third‑party screening across global sanctions, enforcement, and watchlist sources with unified entity resolution and real‑time alerts.
| Name | Issuer | Status |
|---|---|---|
| ACF List of War Enablers | Anti-Corruption Foundation | |
| African Development Bank Debarred Entities | African Development Bank Group | |
| Argentina Members of Parliament | Honorable Cámara de Diputados de la Nación Argentina | |
| Argentina RePET Sanctions | Ministerio de Justicia | |
| Armenia Public Officials and Associates | Hetq Online | |
| Asian Development Bank Sanctions | Asian Development Bank | |
| Australian Sanctions Consolidated List | Department of Foreign Affairs and Trade | |
| Democratic People's Republic Of Korea (North Korea) Sanctions Regime | Department of Foreign Affairs and Trade | |
| Former Federal Republic Of Yugoslavia Sanctions Regime | Department of Foreign Affairs and Trade | |
| Iran Sanctions Regime | Department of Foreign Affairs and Trade |
Sign up to unlock Shandong Lukang Pharmaceutical Co., Ltd.’s sanctions, enforcement, and watchlist risk profile.
View Full ReportESG
Verification of declared ESG commitments and certifications with evidence links, score signals, and status updates across E, S, and G.
| Name | Status |
|---|---|
| Sustainable Finance Disclosure Regulation | |
| Global Reporting Initiative Standards | |
| EU Taxonomy Regulation | |
| EU Corporate Sustainability Reporting Directive | |
| California Transparency in Supply Chains Act | |
| EU Non-Financial Reporting Directive | |
| ISO 14001 | |
| Sustainability Accounting Standards Board Standards | |
| Task Force on Climate-related Financial Disclosures | |
| UN Guiding Principles on Business and Human Rights |
Sign up to unlock Shandong Lukang Pharmaceutical Co., Ltd.’s ESG commitments, certifications, and controversy signals.
View Full ReportCybersecurity
Verification of adherence to recognized security standards, mapping control coverage and gaps affecting third‑party and supply‑chain risk.
| Certification | Status |
|---|---|
| General Data Protection Regulation | |
| Digital Operational Resilience Act | |
| Cybersecurity Maturity Model Certification | |
| NIST Cybersecurity Framework | |
| NIST 800-53 Revision 5 | |
| California Consumer Privacy Act | |
| ISO/IEC 27001 | |
| Health Insurance Portability and Accountability Act | |
| Payment Card Industry Data Security Standard | |
| Federal Information Security Modernization Act |
Sign up to unlock Shandong Lukang Pharmaceutical Co., Ltd.’s security standards, control gaps, and exposure risks.
View Full ReportGet Shandong Lukang Pharmaceutical Co., Ltd.'s full Non-Financial Risk Report
By signing up, you agree to our Terms and Privacy Policy.